 | Up a level |
Tutt, Andrew N J; Garber, Judy E; Kaufman, Bella; Viale, Giuseppe; Fumagalli, Debora; Rastogi, Priya; Gelber, Richard D; de Azambuja, Evandro; Fielding, Anitra; Balmaña, Judith; Domchek, Susan M; Gelmon, Karen A; Hollingsworth, Simon J; Korde, Larissa A; Linderholm, Barbro; Bandos, Hanna; Senkus, Elżbieta; Suga, Jennifer M; Shao, Zhimin; Pippas, Andrew W; ... (2021). Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. The New England journal of medicine, 384(25), pp. 2394-2405. Massachusetts Medical Society 10.1056/NEJMoa2105215
Leone, Jose P; Cole, Bernard F; Regan, Meredith M; Thürlimann, Beat; Coates, Alan S; Rabaglio, Manuela; Giobbie-Hurder, Anita; Gelber, Richard D; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, Istvan; Bonnefoi, Herve; Wardley, Andrew; Goldhirsch, Aron; Di Leo, Angelo; Colleoni, Marco; Vaz-Luis, Ines; Lin, Nancy U (2021). Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial. Cancer, 127(5), pp. 700-708. Wiley 10.1002/cncr.33318
Rabaglio, Manuela; Sun, Zhuoxin; Maibach, Rudolf; Giobbie-Hurder, Anita; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, István; Bonnefoi, Hervé; Wardley, Andrew; Ruepp, Barbara; Castiglione, Monica; Coates, Alan S; Gelber, Richard D; Goldhirsch, Aron; Colleoni, Marco; Thürlimann, Beat; Regan, Meredith M (2020). Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial. Breast cancer research and treatment, 185(3), pp. 697-707. Springer 10.1007/s10549-020-05981-z
Ribi, Karin; Luo, Weixiu; Walley, Barbara A; Burstein, Harold J; Chirgwin, Jacquie; Ansari, Rafat H; Salim, Muhammed; van der Westhuizen, Andre; Abdi, Ehtesham; Francis, Prudence A; Chia, Stephen; Harvey, Vernon J; Giobbie-Hurder, Anita; Fleming, Gini F; Pagani, Olivia; Di Leo, Angelo; Colleoni, Marco; Gelber, Richard D; Goldhirsch, Aron; Coates, Alan S; ... (2020). Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy. Breast cancer research and treatment, 181(2), pp. 347-359. Springer 10.1007/s10549-020-05622-5
Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; ... (2020). Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British journal of cancer, 122(7), p. 1119. Nature Publishing Group 10.1038/s41416-019-0709-x
Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; ... (2019). Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British journal of cancer, 120(10), pp. 959-967. Springer Nature 10.1038/s41416-019-0435-4
Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seamus; Di Lauro, Vincenzo; Gombos, Andrea; ... (2018). Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Lancet oncology, 19(1), pp. 127-138. Elsevier 10.1016/S1470-2045(17)30715-5
Ribi, Karin; Coates, Alan; Blacher, Lynette; Regan, Meredith M; Gelber, Richard D; Bernhard, Jürg (2018). Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al. Quality of life research, 27(1), pp. 149-152. Springer 10.1007/s11136-017-1695-1
Saha, Poornima; Regan, Meredith M; Pagani, Olivia; Francis, Prudence A; Walley, Barbara A; Ribi, Karin; Bernhard, Jürg; Luo, Weixiu; Gómez, Henry L; Burstein, Harold J; Parmar, Vani; Torres, Roberto; Stewart, Josephine; Bellet, Meritxell; Perelló, Antonia; Dane, Faysal; Moreira, Antonio; Vorobiof, Daniel; Nottage, Michelle; Price, Karen N; ... (2017). Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. Journal of clinical oncology, 35(27), pp. 3113-3122. American Society of Clinical Oncology 10.1200/JCO.2016.72.0946
Borgquist, Signe; Giobbie-Hurder, Anita; Ahern, Thomas P; Garber, Judy E; Colleoni, Marco; Láng, István; Debled, Marc; Ejlertsen, Bent; von Moos, Roger; Smith, Ian; Coates, Alan S; Goldhirsch, Aron; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Regan, Meredith M; Thürlimann, Beat (2017). Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. Journal of clinical oncology, 35(11), pp. 1179-1188. American Society of Clinical Oncology 10.1200/JCO.2016.70.3116
Johansson, Harriet; Gray, Kathryn P; Pagani, Olivia; Regan, Meredith M; Viale, Giuseppe; Aristarco, Valentina; Macis, Debora; Puccio, Antonella; Roux, Susanne; Maibach, Rudolf; Colleoni, Marco; Rabaglio, Manuela; Price, Karen N; Coates, Alan S; Gelber, Richard D; Goldhirsch, Aron; Kammler, Roswitha; Bonanni, Bernardo; Walley, Barbara A (2016). Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast cancer research, 18(1), p. 110. BioMed Central Ltd. 10.1186/s13058-016-0771-8
Chirgwin, Jacquie H; Giobbie-Hurder, Anita; Coates, Alan S; Price, Karen N; Ejlertsen, Bent; Debled, Marc; Gelber, Richard D; Goldhirsch, Aron; Smith, Ian; Rabaglio, Manuela; Forbes, John F; Neven, Patrick; Láng, István; Colleoni, Marco; Thürlimann, Beat (2016). Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. Journal of clinical oncology, 34(21), pp. 2452-2459. American Society of Clinical Oncology 10.1200/JCO.2015.63.8619
Francis, Prudence A; Regan, Meredith M; Fleming, Gini F; Láng, István; Ciruelos, Eva; Bellet, Meritxell; Bonnefoi, Hervé R; Climent, Miguel A; Da Prada, Gian Antonio; Burstein, Harold J; Martino, Silvana; Davidson, Nancy E; Geyer, Charles E; Walley, Barbara A; Coleman, Robert; Kerbrat, Pierre; Buchholz, Stefan; Ingle, James N; Winer, Eric P; Rabaglio, Manuela; ... (2015). Adjuvant ovarian suppression in premenopausal breast cancer. New England journal of medicine NEJM, 372(5), pp. 436-446. Massachusetts Medical Society MMS 10.1056/NEJMoa1412379
Pagani, Olivia; Regan, Meredith M; Walley, Barbara A; Fleming, Gini F; Colleoni, Marco; Láng, István; Gomez, Henry L; Tondini, Carlo; Burstein, Harold J; Perez, Edith A; Ciruelos, Eva; Stearns, Vered; Bonnefoi, Hervé R; Martino, Silvana; Geyer, Charles E; Pinotti, Graziella; Puglisi, Fabio; Crivellari, Diana; Ruhstaller, Thomas; Winer, Eric P; ... (2014). Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. New England journal of medicine NEJM, 371(2), pp. 107-118. Massachusetts Medical Society MMS 10.1056/NEJMoa1404037
Regan, Meredith M; Pagani, Olivia; Fleming, Gini F; Walley, Barbara A; Price, Karen N; Rabaglio, Manuela; Maibach, Rudolf; Ruepp, Barbara; Coates, Alan S; Goldhirsch, Aron; Colleoni, Marco; Gelber, Richard D; Francis, Prudence A (2013). Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials. Breast, 22(6), pp. 1094-1100. Elsevier 10.1016/j.breast.2013.08.009
Ewertz, Marianne; Gray, Kathryn P; Regan, Meredith M; Ejlertsen, Bent; Price, Karen N; Thürlimann, Beat; Bonnefoi, Hervé; Forbes, John F; Paridaens, Robert J; Rabaglio, Manuela; Gelber, Richard D; Colleoni, Marco; Láng, István; Smith, Ian E; Coates, Alan S; Goldhirsch, Aron; Mouridsen, Henning T (2012). Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial. Journal of clinical oncology, 30(32), pp. 3967-75. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.40.8666
Regan, Meredith M; Neven, Patrick; Giobbie-Hurder, Anita; Goldhirsch, Aron; Ejlertsen, Bent; Mauriac, Louis; Forbes, John F; Smith, Ian; Láng, István; Wardley, Andrew; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Coates, Alan S; Thürlimann, Beat; BIG 1-98 Collaborative Group, ; International Breast Cancer Study Group (IBCSG), (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet oncology, 12(12), pp. 1101-8. Oxford: Elsevier 10.1016/S1470-2045(11)70270-4
Phillips, Kelly-Anne; Aldridge, Julie; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg (2011). Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast cancer research and treatment, 126(1), pp. 221-6. Dordrecht: Springer US; http://www.springer-ny.com 10.1007/s10549-010-1235-y
Phillips, Kelly-Anne; Ribi, Karin; Sun, Zhuoxin; Stephens, Alisa; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg (2010). Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast, 19(5), pp. 388-95. Amsterdam: Elsevier 10.1016/j.breast.2010.03.025
Gelber, Richard D; Aebi, Stefan (2009). Endocrine therapy plus zoledronic acid in premenopausal breast cancer. New England journal of medicine NEJM, 360(22), 2367; author reply 2369-70. Waltham, Mass.: Massachusetts Medical Society MMS
Pagani, Olivia; Price, Karen N; Gelber, Richard D; Castiglione-Gertsch, Monica; Holmberg, Stig B; Lindtner, Jurij; Thürlimann, Beat; Collins, John; Fey, Martin F; Coates, Alan S; Goldhirsch, Aron (2009). Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast cancer research and treatment, 117(2), pp. 319-24. Dordrecht: Springer 10.1007/s10549-008-0282-0
Wapnir, Irene L; Aebi, Stefan; Geyer, Charles E; Zahrieh, David; Gelber, Richard D; Anderson, Stewart J; Robidoux, André; Bernhard, Jürg; Maibach, Rudolf; Castiglione-Gertsch, Monica; Coates, Alan S; Piccart, Martine J; Clemons, Mark J; Costantino, Joseph P; Wolmark, Norman (2008). A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37. Clinical breast cancer, 8(3), pp. 287-92. New York, N.Y.: Elsevier 10.3816/CBC.2008.n.035
Crivellari, Diana; Sun, Zhuoxin; Coates, Alan S; Price, Karen N; Thürlimann, Beat; Mouridsen, Henning; Mauriac, Louis; Forbes, John F; Paridaens, Robert J; Castiglione-Gertsch, Monica; Gelber, Richard D; Colleoni, Marco; Láng, István; Del Mastro, Lucia; Gladieff, Laurence; Rabaglio, Manuela; Smith, Ian E; Chirgwin, Jacquie H; Goldhirsch, Aron (2008). Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. Journal of clinical oncology, 26(12), pp. 1972-9. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.14.0459
Karlsson, Per; Cole, Bernard F; Price, Karen N; Coates, Alan S; Castiglione-Gertsch, Monica; Gusterson, Barry A; Murray, Elizabeth; Lindtner, Jurij; Collins, John P; Holmberg, Stig B; Fey, Martin F; Thürlimann, Beat; Crivellari, Diana; Forbes, John F; Gelber, Richard D; Goldhirsch, Aron; Wallgren, Arne (2007). The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. Journal of clinical oncology, 25(15), pp. 2019-26. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.8152
Mouridsen, Henning; Keshaviah, Aparna; Coates, Alan S; Rabaglio, Manuela; Castiglione-Gertsch, Monica; Sun, Zhuoxin; Thürlimann, Beat; Mauriac, Louis; Forbes, John F; Paridaens, Robert; Gelber, Richard D; Colleoni, Marco; Smith, Ian; Price, Karen N; Goldhirsch, Aron (2007). Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. Journal of clinical oncology, 25(36), pp. 5715-22. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.12.1665
Suter, Thomas M; Procter, Marion; van Veldhuisen, Dirk J; Muscholl, Michael; Bergh, Jonas; Carlomagno, Chiara; Perren, Timothy; Passalacqua, Rodolfo; Bighin, Claudia; Klijn, Jan G M; Ageev, Fail T; Hitre, Erika; Groetz, Juergen; Iwata, Hiroji; Knap, Malgorzata; Gnant, Michael; Muehlbauer, Susanne; Spence, Alison; Gelber, Richard D and Piccart-Gebhart, Martine J (2007). Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. Journal of clinical oncology, 25(25), pp. 3859-65. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.1611
